Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MOH To Jointly Fund, Manage Hospitals With Shanghai And Guangdong Governments

This article was originally published in PharmAsia News

Executive Summary

China's Ministry of Health has signed separate agreements with Shanghai municipal and Guangdong provincial governments to fund and administer 12 ministry-managed hospitals in the two regions. The parties will jointly manage the hospitals as well as actively strengthen the guidelines on hospital economics, treatment, education and R&D. The governments of the two regions will include these hospitals into their local health care development planning. In addition, Shanghai city will support the establishment of key medical disciplines, matching MOH's funding dollar-for-dollar. The move represents an innovative strategy in pushing health care management system reform, and will serve as a pioneering model for the country. (Click here for more - Chinese Language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071052

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel